Data on:

Illumina

1 day ago
bookmarkBookmark

Illumina is a company. It is in San Diego, the United States and it has a male CEO called Francis A. deSouza. It was founded in 1998 and is part of the Health Care sector, specifically in the Health Care Providers & Services industry.

Key facts

plus See more facts
link LinkedIn: 306K followers
link Instagram
link Facebook
link X (Twitter): 100K followers


Extract data

Download datasets about Illumina:

dataset Dataset of stocks from Illumina:

Illumina is one of the companies in the United States, companies in Health Care Providers & Services, companies in Health Care, companies in Francis A. deSouza, companies in San Diego and 3,456,835 companies in our database.

Talking Points

  • Illumina | Sequencing and array solutions to fuel genomic discoveries
  • Illumina sequencing and array technologies drive advances in life science research, translational and consumer genomics, and molecular diagnostics.
  • Dedicated to advancing human health by unlocking the power of the #genome. 🧬
  • Unlocking the Power of the Genome | At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible.
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.
  • イルミナ株式会社 | 遺伝研究をサポートするシーケンスとマイクロアレイテクノロジー
  • イルミナの革新的なシーケンスとアレイテクノロジーは、ライフサイエンス、トランスレーショナル研究、消費者ゲノミクス、分子診断の分野において画期的な進歩を支えています。
  • Unlocking the Power of the Genome | At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in ...
  • Infectious Diseases & NGS
  • As a hypothesis-free method, NGS can distinguish between infectious disease strains that differ by as little as one SNP, and replace multiple tests.
  • http://www.idbydna.com Industries Biotechnology Research Company size 51-200 employees Headquarters Salt Lake City, UT Type Privately Held Founded 2014 Locations Primary 675 Arapeen Drive Suite 301...
  • BlueBee Genomics Cloud Computing
  • Delivering a streamlined way for users to analyze, explore, and manage large-scale genomics data in the cloud.
  • BlueBee serves diagnostic and research assay manufacturers with fit-for-purpose data solutions that extend the go-to-market strategy for the assay...
  • Illumina DRAGEN Bio-IT Platform | Variant calling & genomics software
  • The Illumina DRAGEN Bio-IT Platform provides accurate, comprehensive, and efficient analysis of next-generation sequencing data.

Related

Connected or similar to Illumina: .

This dashboard is based on data from: YAHOO-FIN, YFINANCE, Twitter.

This content is available under the CC BY 4.0 license.